AIQ Solutions
About AIQ Solutions
AIQ Solutions is a healthcare artificial intelligence company dedicated to improving treatment outcomes for patients with complex diseases, particularly those with late-stage and metastatic cancer. The company’s core technology, known as TRAQinform IQ or the Quantitative Total-body Imaging Solutions (QTS) Platform, provides advanced software solutions for analyzing medical imaging data. Instead of biopsies, AIQ Solutions utilizes radiologic images from computed tomography (CT) and positron emission tomography (PET) scans to identify and quantify changes in individual lesions throughout the body.
This technology generates detailed reports that help oncologists pinpoint which cancers are responding to treatment, offering unique intelligence about the heterogeneity of treatment response. By providing quantitative and spatial information on changes in regions of interest over time, AIQ Solutions enables clinicians to more precisely adjust therapies and optimize clinical outcomes. The software is designed to integrate easily into existing workflows, leveraging cloud-based image analysis to support data-driven decision-making and advance personalized medicine in oncology.
Focus Areas
Business Intelligence
| Key Investors | Capital Midwest Fund, Rock River Capital Partners, 30Ventures, Wisconsin Investment Partners, BrightStar Wisconsin Foundation, WARF Ventures, NVNG |
| Partnerships | Blackford Analysis, Lucem Health Innovation Collaborative, Flywheel, Scientist.com, Australian Centre for Quantitative Imaging (ACQI) / University of Western Australia |
| Technology | TRAQinform IQ (software medical device), QTS (Quantitative Total-body Imaging Solutions) Platform, cloud-native, AI-driven, 3D segmentation and quantitation, lesion-level analysis |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, AIQ Solutions stands out by offering a fundamentally more comprehensive and granular understanding of a patient's cancer. Instead of relying on limited target lesion assessments, TRAQinform IQ provides visual and written reports detailing the response of *every* individual lesion, highlighting those responding (green) versus those progressing (red). This level of detail moves beyond a binary 'responding or progressing' assessment, enabling oncologists to understand the intra-patient heterogeneity of treatment response and make more precise, personalized treatment adjustments. The technology's ability to analyze hundreds of lesions simultaneously, which is clinically infeasible manually, saves valuable time and provides superior prognostic power compared to standard methods like RECIST and PERCIST. Ultimately, it empowers physicians with actionable intelligence to optimize therapies and improve patient outcomes in complex late-stage and metastatic cancer cases.
AIQ Solutions' technology is designed for easy integration into existing clinical workflows. It operates as a cloud-based service, allowing for remote processing of serial PET/CT and other radiographic studies. They have also established partnerships, such as with Blackford Analysis, to integrate their clinical decision support technology into enterprise AI platforms, facilitating broader access and streamlined deployment within healthcare systems.
Reviews & Opinions
Videos
News, demos, and interviews about AIQ Solutions.
Videos load interactively. If none appear, search YouTube for AIQ Solutions →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]